Biologics and Biosimilars Market 2023 by Regions(Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
Date: Mar, 2021 | 178 Pages | Report ID: MRI_54041
Biologics and Biosimilars Market 2023 by Regions(Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
ID : MRI54041 | Date : Mar, 2021 | Pages :
178 | Region : Global |
Publisher : MRI
The Biologics and Biosimilars market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Biologics and Biosimilars market size is expected to gain market growth in the forecast period of 2023 to 2028, with a CAGR of xx%% in the forecast period of 2023 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Competitive Landscape and Biologics and Biosimilars Market Share Analysis
Product Type Coverage (Market Size Forecast, Major Company of Product Type etc.):
Bio-PET
PHA
Bio-PE
Starch Blends
PLA
Others
By Application
Packing Industry
Automotive Industry
Bottles manufacturing
Others
Biologics and Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Biologics and Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Biologics and Biosimilars sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Biologics and Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Biologics and Biosimilars markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Biologics and Biosimilars market.
By Region:
North America
By Country (US, Canada, Mexico)
By Component
By System
By Application
Western Europe
By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
By Component
By System
By Application
Eastern Europe
By Country (Russia, Turkey, Rest of Eastern Europe)
By Component
By System
By Application
Asia Pacific
By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
By Component
By System
By Application
Middle East
By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
By Component
By System
By Application
Rest of the World
By Region (South America, Africa)
By Component
By System
By Application
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Biologics and Biosimilars market for the forecast period 2023 - 2028?
• What are the driving forces in the Biologics and Biosimilars market for the forecast period 2023 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Biologics and Biosimilars industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.2 America Market Size and Growth
Figure America Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBiologics and Biosimilars Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Biologics and Biosimilars Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Biologics and Biosimilars Market Forecast and Growth Rate, 2020E-2026F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Figure Global Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
2.3 Global Production by Type
Table Global Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Global Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
2.4 Global Consumption by End-Use
Table Global Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
2.5 Global Consumption by Region
Table Global Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Figure Europe Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
3.3 Europe Production by Type
Table Europe Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Europe Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
3.4 Europe Consumption by End-Use
Table Europe Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
3.5 Europe Consumption by Region
Table Europe Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Figure America Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
4.3 America Production by Type
Table America Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure America Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
4.4 America Consumption by End-Use
Table America Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
4.5 America Consumption by Region
Table America Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Figure Asia Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
5.3 Asia Production by Type
Table Asia Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Asia Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
5.4 Asia Consumption by End-Use
Table Asia Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
5.5 Asia Consumption by Region
Table Asia Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Figure Oceania Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
6.4 Oceania Consumption by End-Use
Table Oceania Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
6.5 Oceania Consumption by Region
Table Oceania Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Biologics and Biosimilars Revenue (Million USD), Cost (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Figure Africa Biologics and Biosimilars Consumption Value (Million USD) and Growth Rate List, 2015-2020
7.3 Africa Production by Type
Table Africa Biologics and Biosimilars Revenue by Type, 2015-2020 (Million USD)
Figure Africa Biologics and Biosimilars Revenue Share by Type in 2020 (Million USD)
7.4 Africa Consumption by End-Use
Table Africa Biologics and Biosimilars Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Biologics and Biosimilars Consumption Value Share by End-Use in 2020 (Million USD)
7.5 Africa Consumption by Region
Table Africa Biologics and Biosimilars Consumption Value by Region, 2015-2020 (Million USD)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Biologics and Biosimilars Production Forecast
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast 2020E-2026F (Million USD)
8.2 Global Biologics and Biosimilars Forecast by Type
Table Global Biologics and Biosimilars Revenue by Type, 2020E-2026F (Million USD)
Figure Global Biologics and Biosimilars Revenue Share by Type in 2025 (Million USD)
8.3 Global Biologics and Biosimilars Forecast by End-Use (2020E-2026F)
Table Global Biologics and Biosimilars Consumption Value by End-Use, 2020E-2026F (Million USD)
Figure Global Biologics and Biosimilars Consumption Value Share by End-Use in 2025 (Million USD)
8.4 Global Biologics and Biosimilars Forecast by Region (2020E-2026F)
Table Global Biologics and Biosimilars Consumption Value by Region, 2020E-2026F (Million USD)
Figure Global Biologics and Biosimilars Consumption Value Share by Region in 2025 (Million USD)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 NatureWorks
9.1.1 NatureWorks Profile
Table NatureWorks Overview List
9.1.2 NatureWorks Products & Services
9.1.3 NatureWorks Company Dynamics & News
9.1.4 NatureWorks Business Operation Conditions
Table Business Operation of NatureWorks (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Braskem
9.2.1 Braskem Profile
Table Braskem Overview List
9.2.2 Braskem Products & Services
9.2.3 Braskem Company Dynamics & News
9.2.4 Braskem Business Operation Conditions
Table Business Operation of Braskem (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 BASF
9.3.1 BASF Profile
Table BASF Overview List
9.3.2 BASF Products & Services
9.3.3 BASF Company Dynamics & News
9.3.4 BASF Business Operation Conditions
Table Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Arkema
9.4.1 Arkema Profile
Table Arkema Overview List
9.4.2 Arkema Products & Services
9.4.3 Arkema Company Dynamics & News
9.4.4 Arkema Business Operation Conditions
Table Business Operation of Arkema (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 DuPont
9.5.1 DuPont Profile
Table DuPont Overview List
9.5.2 DuPont Products & Services
9.5.3 DuPont Company Dynamics & News
9.5.4 DuPont Business Operation Conditions
Table Business Operation of DuPont (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Novamont
9.6.1 Novamont Profile
Table Novamont Overview List
9.6.2 Novamont Products & Services
9.6.3 Novamont Company Dynamics & News
9.6.4 Novamont Business Operation Conditions
Table Business Operation of Novamont (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Corbion
9.7.1 Corbion Profile
Table Corbion Overview List
9.7.2 Corbion Products & Services
9.7.3 Corbion Company Dynamics & News
9.7.4 Corbion Business Operation Conditions
Table Business Operation of Corbion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Metabolix
9.8.1 Metabolix Profile
Table Metabolix Overview List
9.8.2 Metabolix Products & Services
9.8.3 Metabolix Company Dynamics & News
9.8.4 Metabolix Business Operation Conditions
Table Business Operation of Metabolix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 PSM
9.9.1 PSM Profile
Table PSM Overview List
9.9.2 PSM Products & Services
9.9.3 PSM Company Dynamics & News
9.9.4 PSM Business Operation Conditions
Table Business Operation of PSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 PolyOne
9.10.1 PolyOne Profile
Table PolyOne Overview List
9.10.2 PolyOne Products & Services
9.10.3 PolyOne Company Dynamics & News
9.10.4 PolyOne Business Operation Conditions
Table Business Operation of PolyOne (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Biome Bioplastics
9.11.1 Biome Bioplastics Profile
Table Biome Bioplastics Overview List
9.11.2 Biome Bioplastics Products & Services
9.11.3 Biome Bioplastics Company Dynamics & News
9.11.4 Biome Bioplastics Business Operation Conditions
Table Business Operation of Biome Bioplastics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Biomer
9.12.1 Biomer Profile
Table Biomer Overview List
9.12.2 Biomer Products & Services
9.12.3 Biomer Company Dynamics & News
9.12.4 Biomer Business Operation Conditions
Table Business Operation of Biomer (Sales Revenue, Cost, Gross Margin)
9.13 FKuR
9.13.1 FKuR Profile
Table FKuR Overview List
9.13.2 FKuR Products & Services
9.13.3 FKuR Company Dynamics & News
9.13.4 FKuR Business Operation Conditions
Table Business Operation of FKuR (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Trellis Bioplastics
9.14.1 Trellis Bioplastics Profile
Table Trellis Bioplastics Overview List
9.14.2 Trellis Bioplastics Products & Services
9.14.3 Trellis Bioplastics Company Dynamics & News
9.14.4 Trellis Bioplastics Business Operation Conditions
Table Business Operation of Trellis Bioplastics (Sales Revenue, Cost, Gross Margin)
9.15 Kingfa
9.15.1 Kingfa Profile
Table Kingfa Overview List
9.15.2 Kingfa Products & Services
9.15.3 Kingfa Company Dynamics & News
9.15.4 Kingfa Business Operation Conditions
Table Business Operation of Kingfa (Sales Revenue, Cost, Gross Margin)
9.16 Cardia Bioplastics
9.16.1 Cardia Bioplastics Profile
Table Cardia Bioplastics Overview List
9.16.2 Cardia Bioplastics Products & Services
9.16.3 Cardia Bioplastics Company Dynamics & News
9.16.4 Cardia Bioplastics Business Operation Conditions
Table Business Operation of Cardia Bioplastics (Sales Revenue, Cost, Gross Margin)
9.17 Grabio
9.17.1 Grabio Profile
Table Grabio Overview List
9.17.2 Grabio Products & Services
9.17.3 Grabio Company Dynamics & News
9.17.4 Grabio Business Operation Conditions
Table Business Operation of Grabio (Sales Revenue, Cost, Gross Margin)
9.18 MHG
9.18.1 MHG Profile
Table MHG Overview List
9.18.2 MHG Products & Services
9.18.3 MHG Company Dynamics & News
9.18.4 MHG Business Operation Conditions
Table Business Operation of MHG (Sales Revenue, Cost, Gross Margin)
9.19 Myriant
9.19.1 Myriant Profile
Table Myriant Overview List
9.19.2 Myriant Products & Services
9.19.3 Myriant Company Dynamics & News
9.19.4 Myriant Business Operation Conditions
Table Business Operation of Myriant (Sales Revenue, Cost, Gross Margin)
9.20 Mitsubishi
9.20.1 Mitsubishi Profile
Table Mitsubishi Overview List
9.20.2 Mitsubishi Products & Services
9.20.3 Mitsubishi Company Dynamics & News
9.20.4 Mitsubishi Business Operation Conditions
Table Business Operation of Mitsubishi (Sales Revenue, Cost, Gross Margin)
9.21 Zhejiang Hisun Biomaterials
9.21.1 Zhejiang Hisun Biomaterials Profile
Table Zhejiang Hisun Biomaterials Overview List
9.21.2 Zhejiang Hisun Biomaterials Products & Services
9.21.3 Zhejiang Hisun Biomaterials Company Dynamics & News
9.21.4 Zhejiang Hisun Biomaterials Business Operation Conditions
Table Business Operation of Zhejiang Hisun Biomaterials (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Biologics and Biosimilars Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Biologics and Biosimilars Sales Revenue Share, 2015-2020E, by Companies, in USD
10.2 Regional Market Concentration
Figure Europe Biologics and Biosimilars Market Concentration Ratio in 2020E
Figure America Biologics and Biosimilars Market Concentration Ratio in 2020E
Figure Asia Biologics and Biosimilars Market Concentration Ratio in 2020E
Figure Oceania Biologics and Biosimilars Market Concentration Ratio in 2020E
Figure Africa Biologics and Biosimilars Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Biologics and Biosimilars INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Biologics and Biosimilars INDUSTRY SUMMARY & CONCLUSION
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.
